News & Insights
OTIF Ventures Hosts Investor Showcase in London
OTIF Ventures welcomed portfolio company leaders, investors and guests to its recent London Showcase, formally introducing the firm’s new trading name alongside a selection of high-potential prospective investments for Tranche 15
The evening reflected the next stage in our evolution, building on more than a decade of investing in high-potential university spinouts and research-led businesses.
With an interview between our Founding Partner George Robinson and Yuri Bender, Editor-in-Chief of Financial Times PWM Magazine, the event opened with a discussion on the OTIF journey to date, our investment philosophy and the opportunities we see emerging across the UK innovation ecosystem.
Guests then heard presentations from a selection of businesses drawn from both our existing portfolio and current investment pipeline, including:
- Evolito – advanced electric propulsion systems
- Prenostics – precision oncology diagnostics
- Newrotex – next-generation neurotechnology
- Caristo Diagnostics – AI-powered cardiovascular imaging
The evening concluded with an overview of Tranche 15, which we believe represents one of the strongest pipelines we have assembled to date, combining early-stage opportunities with increasingly mature EIS-eligible businesses supported by recent changes to the market landscape. We would like to thank all those who attended the event, as well as those who have since subscribed to Tranche 15. For investors unable to join us on the evening, further information and showcase materials are available through our investor portal.
If you would like to discuss Tranche 15 or upcoming opportunities with the OTIF Ventures team, please get in touch.